Cardiothoracic surgery is the branch of surgery concerned with operative treatment of diseases affecting the heart, great vessels, lungs, esophagus, chest wall, diaphragm, and mediastinum. Its principal divisions are adult cardiac surgery, congenital cardiac surgery, and general thoracic surgery. Their organization varies internationally: some training systems combine them within one specialty, whereas others recognize cardiac and thoracic surgery as separate disciplines. Esophageal surgery, major aortic surgery, and transplantation may also be shared with other surgical specialties.
The field encompasses operations ranging from removal of a small lung nodule to replacement of the heart or reconstruction of a newborn’s circulation. Its development depended on advances in anesthesia, infection control, blood banking, imaging, artificial circulation, and intensive care. Contemporary practice combines open operations with video-assisted, robotic, catheter-based, and hybrid procedures. Treatment selection therefore involves not only whether an operation is technically possible, but also its expected durability, physiological consequences, and comparative outcomes.
Scope and historical development
The chest presents distinctive surgical problems because it contains organs whose functions cannot simply be interrupted. Opening the pleural cavity alters the pressure relationships that permit breathing; opening the heart can disrupt circulation within seconds. Early progress consequently depended as much on control of respiration and circulation as on operative technique. The emergence of reliable endotracheal anesthesia, positive-pressure ventilation, and blood transfusion made increasingly complex procedures feasible.
Several late nineteenth- and early twentieth-century operations established that thoracic structures could be treated surgically. In 1896, Ludwig Rehn successfully sutured a penetrating wound of the heart in Frankfurt. In 1933, Evarts Graham and colleagues performed a successful one-stage pneumonectomy for lung cancer. Robert Gross and John Hubbard reported successful surgical ligation of a patent ductus arteriosus in 1938, demonstrating that a congenital cardiovascular abnormality could be corrected directly.
An important distinction developed between closed-heart procedures, performed without opening the cardiac chambers, and open-heart operations requiring control of intracardiac blood flow. In 1944, Alfred Blalock, working with Helen Taussig and Vivien Thomas, introduced a systemic-to-pulmonary arterial shunt for children with severely reduced pulmonary blood flow. In 1953, John Gibbon successfully used a heart–lung machine to close an atrial septal defect. These developments helped establish the technical foundations of modern congenital and adult cardiac surgery.
The following decades brought prosthetic heart valves, reproducible coronary bypass techniques, and transplantation. René Favaloro helped establish saphenous-vein coronary bypass surgery in 1967. In December of the same year, Christiaan Barnard performed the first human-to-human heart transplant. Initial transplantation outcomes were constrained by rejection and infection; improved organ preservation, recipient selection, and immunosuppressive treatment subsequently made transplantation a durable clinical therapy.
General thoracic surgery developed along a partly independent trajectory, emphasizing lung resection, esophageal reconstruction, treatment of pleural infection, and chest-wall surgery. From the late twentieth century, minimally invasive surgery changed access to the chest without necessarily changing the underlying operation. Video-assisted thoracic surgery became established for many pulmonary procedures, while smaller-incision cardiac surgery and catheter-based interventions altered the division of work between surgeons and cardiologists. Modern cardiothoracic surgery is therefore defined more consistently by the diseases and anatomical regions it treats than by a single incision, instrument, or operative method.
Operative physiology, access, and artificial circulation
Cardiothoracic operations require close control of oxygen delivery, blood flow, temperature, and coagulation. Systemic oxygen delivery depends on cardiac output and arterial oxygen content; the latter is determined chiefly by hemoglobin concentration and oxygen saturation. During surgery, changes in these variables can affect the brain, kidneys, and other organs even when the operative field itself appears satisfactory. Monitoring consequently integrates blood pressure, blood gases, urine output, electrocardiography, and, in many cardiac operations, transesophageal echocardiography.
A median sternotomy divides the breastbone and provides broad access to the heart and proximal great vessels. Thoracotomy enters between the ribs, providing access to a lung, the esophagus, or part of the aorta. Video-assisted and robotic techniques use smaller ports or incisions, but still require safe exposure, vascular control, and a plan for conversion to an open operation. In thoracic surgery, a double-lumen endotracheal tube or bronchial blocker often permits one-lung ventilation: the operative lung is deflated while the other lung supports gas exchange. This improves exposure but introduces ventilation–perfusion imbalance and potential hypoxemia.
Cardiopulmonary bypass temporarily replaces the pumping and gas-exchange functions of the heart and lungs. Venous blood is drained into an extracorporeal circuit, passes through an oxygenator, and is returned to the arterial circulation by a pump. Systemic anticoagulation, usually with heparin, prevents clot formation within the circuit. Blood contact with artificial surfaces, dilution by circuit fluid, and changes in temperature can contribute to inflammation, coagulation abnormalities, and organ dysfunction.
Many intracardiac operations also require a still, relatively bloodless heart. A clamp isolates the ascending aorta, and cardioplegic solution arrests the myocardium, commonly through a high potassium concentration. Cardioplegia may be delivered through the coronary arteries or retrogradely through the coronary sinus. Temperature control, repeated delivery, and limitation of ischemic time help protect myocardial tissue. Some procedures instead use a beating heart, with or without bypass, depending on the operation and the patient’s physiology.
Major aortic arch reconstruction may require hypothermic circulatory arrest, sometimes combined with selective cerebral perfusion. Cooling reduces metabolic demand, while targeted perfusion supplies the brain during reconstruction. These methods do not abolish the risks of ischemia, embolism, or bleeding. After bypass, the heart resumes responsibility for circulation, heparin is usually reversed with protamine, and the team assesses ventricular function, valve performance, surgical bleeding, and the adequacy of the repair. Separation from bypass is thus a physiological transition rather than merely the removal of a machine.
Coronary artery surgery
Coronary artery bypass grafting creates alternative routes for blood to reach myocardium beyond obstructed coronary arteries. It treats the consequences of coronary artery disease, most commonly caused by atherosclerosis. The operation does not remove the systemic disease process. Its objectives include relief of ischemic symptoms and, in defined anatomical and clinical groups, improvement in long-term outcomes compared with alternative strategies.
The left internal thoracic artery is commonly connected to the left anterior descending coronary artery because this graft has favorable long-term patency. Additional conduits include the radial artery, the right internal thoracic artery, and segments of saphenous vein. Arterial and venous conduits differ in their wall structure, susceptibility to spasm, and patterns of late disease. Competitive flow through a moderately narrowed native artery can reduce flow through an arterial graft, illustrating why conduit choice and target-vessel anatomy are considered together.
Conventional bypass surgery uses cardiopulmonary bypass and cardioplegic arrest. Off-pump surgery constructs the grafts on a beating heart with local mechanical stabilization. Avoiding bypass removes some extracorporeal-circuit effects, but manipulating the beating heart can compromise circulation, and technically difficult targets may be harder to graft. Off-pump surgery is therefore not intrinsically equivalent to a less extensive operation. Outcomes depend on patient selection, the completeness of revascularization, and the team’s experience. Techniques that minimize manipulation of a diseased ascending aorta address an additional source of embolic risk.
The principal alternative is percutaneous coronary intervention, which opens narrowed coronary segments with balloons and usually stents. Comparisons depend on coronary complexity, left-main involvement, ventricular function, diabetes mellitus, operative risk, and the feasibility of complete revascularization. The FREEDOM trial, published in 2012, found that among patients with diabetes and multivessel coronary disease, bypass surgery reduced the composite of death, myocardial infarction, or stroke compared with drug-eluting stent treatment, although stroke occurred more frequently after surgery. Such findings apply to the studied populations rather than to every coronary presentation.
Complications include perioperative myocardial infarction, bleeding, graft failure, wound infection, kidney injury, and neurological events. New-onset atrial fibrillation is also common after cardiac operations. Longer-term graft failure has several mechanisms: early technical problems or thrombosis, subsequent intimal thickening in vein grafts, and later atherosclerotic degeneration. Follow-up therefore concerns both the reconstructed circulation and the continuing vascular disease. Hybrid coronary revascularization combines a surgical arterial graft, often to the anterior descending artery, with catheter treatment of other vessels in selected circumstances.
Heart valves and the thoracic aorta
Valve surgery treats obstruction to forward flow, termed stenosis, and backward leakage, termed regurgitation. These abnormalities impose different loads on the heart: stenosis commonly produces pressure overload, whereas regurgitation produces volume overload. Their consequences depend on severity, duration, ventricular adaptation, pulmonary pressures, and rhythm. Echocardiography defines valve anatomy and hemodynamics, while computed tomography is especially important for aortic anatomy and planning some valve interventions.
Repair preserves native valve tissue whenever a durable reconstruction is feasible. Mitral repair may combine removal or reshaping of abnormal leaflet tissue, artificial chordae, and an annuloplasty ring that restores annular geometry. Replacement substitutes a mechanical or biological prosthesis. Mechanical valves are durable but ordinarily require lifelong treatment with a vitamin K antagonist such as warfarin. Biological valves, made from animal tissue or obtained from human donors in particular applications, are susceptible to structural degeneration. Prosthesis choice therefore involves durability, anticoagulation-related consequences, anatomy, age, and the possibility of future intervention.
Surgery also treats valve infection when structural destruction, uncontrolled infection, or other complications make an operation necessary. Reconstruction may extend beyond the leaflets to an infected annulus or aortic root. These cases differ substantially from elective surgery for degenerative valve disease because infection can damage supporting tissue and produce embolic or systemic complications. The operation is integrated with microbiological investigation and antimicrobial treatment rather than considered a substitute for them.
Aortic surgery addresses aneurysms, aortic dissection, rupture, and other structural disorders. In an acute type A dissection, the ascending aorta is involved; blood entering the aortic wall can cause tamponade, valve dysfunction, rupture, or obstruction of branch vessels. Operations replace the affected ascending aorta and may extend into the root or arch. Root replacement can incorporate a prosthetic valve, as in a composite graft operation, or preserve the native valve when its structure and the underlying disease permit.
Catheter-based treatment has substantially changed valve and aortic practice. Transcatheter aortic valve replacement places a prosthetic valve within the diseased native aortic valve, usually through arterial access, without conventional open valve excision. Endovascular stent grafts exclude selected descending thoracic aortic lesions from circulation. These procedures introduce different anatomical constraints and complications, including vascular injury, paravalvular leakage, conduction disturbance, endoleak, or the need for later reintervention. Surgical, catheter-based, and hybrid approaches are consequently evaluated through multidisciplinary assessment rather than treated as interchangeable versions of one operation.
Congenital cardiac surgery
Congenital heart disease comprises structural abnormalities present at birth, ranging from isolated septal defects to complex arrangements of cardiac chambers and great arteries. Surgical planning depends on the actual pathways of blood flow rather than the diagnostic name alone. Important questions include whether pulmonary blood flow is excessive or restricted, whether systemic and pulmonary circulations communicate adequately, and whether two ventricles can support separate circulations.
Some operations restore near-normal anatomical relationships. Closure of an atrial or ventricular septal defect eliminates an abnormal communication when intervention is required. Repair of tetralogy of Fallot closes the ventricular septal defect and relieves obstruction to pulmonary outflow. In transposition of the great arteries, the arterial switch operation reconnects the great arteries to the appropriate ventricles and transfers the coronary arteries. Coronary transfer is technically critical because the myocardium must retain an adequate blood supply after the reconstruction.
Other malformations cannot be converted into a conventional two-ventricle circulation. Staged palliation for a functionally single ventricle directs systemic venous blood toward the pulmonary arteries, ultimately producing a Fontan circulation in suitable patients. In this arrangement, pulmonary blood flow lacks a normal subpulmonary ventricular pump and depends on favorable pressure relationships and low pulmonary vascular resistance. The resulting physiology can support long-term survival but may also produce chronic venous congestion, exercise limitation, lymphatic abnormalities, liver disease, and rhythm disturbances.
Neonatal cardiac surgery poses particular physiological and technical challenges. Small circulating blood volume magnifies the effects of blood loss and extracorporeal-circuit dilution. Immature organs may be vulnerable to changes in perfusion and oxygen delivery. In some critical defects, the ductus arteriosus temporarily maintains essential systemic or pulmonary flow; prostaglandin treatment can preserve this connection before definitive or staged intervention. Timing is therefore closely connected to the changing circulation after birth, not simply to the infant’s size.
The growing population of adults with repaired congenital heart disease has expanded the specialty beyond childhood. Previous repairs may leave residual obstruction, valve regurgitation, conduits that do not grow with the patient, or scar-related arrhythmias. Reoperations can involve pulmonary valve replacement, aortic procedures, or revision of earlier reconstructions. Assessment also includes exercise capacity, ventricular function, neurodevelopmental outcomes, and the consequences of lifelong altered hemodynamics. The term “repair” consequently does not necessarily mean that continuing surveillance or additional procedures will never be required.
Pulmonary, pleural, mediastinal, and chest-wall surgery
General thoracic surgery treats malignant and nonmalignant disease outside the heart. Lung operations are classified by the amount and anatomical organization of tissue removed. A wedge resection removes a nonanatomical portion; segmentectomy removes one or more bronchopulmonary segments; lobectomy removes a lobe; and pneumonectomy removes an entire lung. Sleeve resection removes an involved airway segment and reconstructs the bronchus, sometimes preserving lung that would otherwise require removal.
For lung cancer, operative planning integrates histological diagnosis, tumor location, nodal involvement, distant spread, and physiological reserve. Biopsy, bronchoscopy, and endobronchial ultrasound-guided nodal sampling can establish diagnosis and stage before resection. Spirometry, gas-transfer measurements, and sometimes exercise testing help estimate the functional consequences of removing lung tissue. Technical resectability and physiological operability are distinct: a tumor may be removable anatomically while the resulting loss of pulmonary function would be poorly tolerated.
Anatomical resection with appropriate lymph-node assessment remains central to surgery for localized non-small-cell lung cancer, but the extent of resection has become more selective. The Japanese JCOG0802 trial, published in 2022, and the North American CALGB/Alliance 140503 trial, published in 2023, supported limited resection strategies in carefully defined populations with small peripheral tumors. Their results do not establish that every small lesion can be managed identically; nodal assessment, tumor characteristics, margins, and the specific form of limited resection remain important. Surgery may also be combined with chemotherapy, immunotherapy, or radiation therapy, depending on disease stage and tumor biology.
Pleural surgery includes drainage and debridement of empyema, removal of a restrictive pleural rind by decortication, and operations for recurrent pneumothorax. Pleurodesis creates adherence between pleural surfaces to reduce recurrence of air or fluid accumulation. These procedures address different mechanisms: infected material requires source control, while recurrent pneumothorax may involve both treatment of leaking lung abnormalities and prevention of renewed pleural separation.
Mediastinal surgery encompasses thymic tumors, cysts, selected germ-cell tumors, and other masses. Thymectomy is used for thymoma and in defined circumstances involving myasthenia gravis. Chest-wall surgery includes removal and reconstruction of tumors, stabilization of selected injuries, and correction of deformities. Reconstruction must preserve protection of the underlying organs and sufficient mechanical stability for breathing. Across these procedures, video-assisted and robot-assisted surgery can reduce access trauma in suitable cases, but oncological clearance, control of major bleeding, and safe reconstruction remain the operative priorities.
Esophageal surgery and reconstruction
Esophageal surgery occupies an anatomical and professional boundary between thoracic and upper gastrointestinal surgery. The esophagus passes through the neck, chest, and abdomen, and its operations may require access to more than one region. Its lack of a serosal covering, segmental blood supply, and close relationship to the airway, aorta, and recurrent laryngeal nerves help explain the technical difficulty of resection and reconstruction.
For esophageal cancer, treatment depends on tumor depth, nodal involvement, histological type, location, and distant spread. Selected superficial tumors can be treated endoscopically, whereas more invasive but localized disease may require esophagectomy within a multimodality program. Endoscopic ultrasound, computed tomography, and other staging investigations distinguish potentially resectable disease from disease requiring a different treatment strategy. The role and sequence of chemotherapy and radiotherapy vary between squamous-cell carcinoma and adenocarcinoma and between treatment protocols.
An esophagectomy removes the diseased segment and usually regional lymphatic tissue, then restores continuity of the digestive tract. The stomach is the most common replacement conduit, although colon or jejunum can be used in particular circumstances. An Ivor Lewis operation combines abdominal and right thoracic phases with an intrathoracic anastomosis. A McKeown operation adds cervical access and places the anastomosis in the neck. Transhiatal approaches avoid a formal thoracic incision but provide different exposure and access to mediastinal lymph nodes.
Major complications include anastomotic leakage, conduit ischemia, pulmonary complications, chyle leakage, and recurrent laryngeal nerve injury. Leakage can contaminate the mediastinum or pleural cavity and lead to sepsis. Chyle leakage follows disruption of the thoracic duct or its branches and can cause substantial fluid, nutritional, and immune-cell losses. Longer-term consequences include anastomotic narrowing, reflux, altered gastric emptying, early satiety, and weight loss. These effects reflect the functional consequences of replacing the esophagus, not solely operative complications.
Nonmalignant esophageal surgery includes treatment of achalasia, selected complications of gastroesophageal reflux disease, diverticula, strictures, and perforation. Achalasia treatment reduces resistance at the lower esophageal sphincter through myotomy or other techniques; it does not restore normal esophageal nerve function. Perforation management depends on its location, timing, containment, associated disease, and the degree of contamination. Repair, drainage, endoscopic closure or stenting, and resection address different clinical circumstances. Minimally invasive and robotic approaches have expanded the technical options, but successful treatment still depends on viable tissue, adequate drainage, and preservation or restoration of alimentary continuity.
Transplantation and mechanical cardiopulmonary support
Heart and lung transplantation replace organs whose function cannot be restored adequately by other treatments. They form part of organ transplantation and depend on donor identification, allocation systems, organ preservation, complex surgery, and lifelong follow-up. Transplantation differs from reconstructive surgery because the implanted tissue remains biologically distinct from the recipient and is vulnerable to immune-mediated injury as well as ordinary infection and structural disease.
Heart transplantation most commonly replaces the recipient’s heart with a donor heart in the normal anatomical position. Surgical connections join the great vessels and atrial structures; bicaval techniques preserve separate superior and inferior vena caval connections. Important early problems include primary graft dysfunction, bleeding, right ventricular failure, and acute rejection. Later outcomes are affected by infection, malignancy, kidney dysfunction, and cardiac allograft vasculopathy, a diffuse disease of the transplanted coronary circulation.
Lung transplantation may replace one lung or both, depending on the underlying disease and other factors. The operation reconnects airways, pulmonary arteries, and pulmonary venous drainage. Airway healing is a special concern because the donor bronchial arterial circulation is generally not directly re-established in standard transplantation. Primary graft dysfunction, infection, airway complications, acute rejection, and chronic lung allograft dysfunction are important determinants of outcome. Heart–lung transplantation is reserved for particular combinations of irreversible cardiac and pulmonary disease.
Immunosuppression commonly combines drugs acting through different mechanisms. These treatments reduce transplant rejection but also increase susceptibility to infection and certain malignancies. Allocation and recipient assessment therefore consider not only the severity of organ failure but also the likelihood that transplantation can provide sustained benefit. Developments in machine perfusion allow selected donor organs to be supported and evaluated outside the body, potentially extending preservation options and improving assessment before implantation.
Mechanical support can substitute for part of cardiopulmonary function without replacing the organ. A ventricular assist device supports ventricular output, most commonly by moving blood from the left ventricle to the aorta. Such devices may bridge a patient to transplantation or provide long-term support for advanced heart failure. Extracorporeal membrane oxygenation uses an external pump and oxygenator for temporary support. Venovenous configurations primarily support gas exchange, whereas venoarterial configurations also support circulation. Neither modality eliminates the underlying disease, and both introduce risks including bleeding, thrombosis, infection, and device-related complications. Their role is determined by the possibility of recovery, transplantation, another definitive intervention, or a clearly defined period of assessment.
Perioperative care, complications, and functional recovery
Cardiothoracic outcomes depend on an extended care pathway rather than the operation alone. Preoperative assessment characterizes the target disease, organ function, nutritional status, physical reserve, and associated conditions. Frailty can identify vulnerability that is not captured by chronological age or an isolated laboratory value. Previous operations, chest irradiation, vascular calcification, and infection may also alter technical risk. Emergency surgery differs fundamentally from elective practice because physiological stabilization and definitive treatment may have to occur simultaneously.
After major cardiac surgery, monitoring focuses on cardiac output, rhythm, bleeding, ventilation, temperature, and organ perfusion. Temporary pacing wires can support rhythm control, and drains remove blood or air from operative spaces. Low cardiac output may result from ventricular dysfunction, inadequate filling, tamponade, ischemia, or mechanical problems with a repair. These causes require distinction because an apparently similar blood-pressure abnormality can arise from very different mechanisms. After lung or esophageal surgery, additional concerns include air leaks, retained secretions, aspiration, and anastomotic integrity.
Bleeding reflects both surgical sources and disturbances of blood coagulation. Cardiopulmonary bypass, hypothermia, platelet dysfunction, and pre-existing antithrombotic treatment may contribute. Neurological complications include stroke, delirium, and other cognitive disturbances; their mechanisms can involve embolism, inflammation, hypoperfusion, and pre-existing vascular disease. Kidney injury may arise from hemodynamic instability, inflammation, or other perioperative insults. Deep sternal wound infection and mediastinitis are uncommon but serious complications of sternotomy.
Pain control has direct functional consequences because painful breathing and coughing can impair secretion clearance and mobility. Analgesic strategies may combine regional techniques and several drug classes to limit reliance on any single agent. Enhanced recovery after surgery programs organize measures such as nutritional assessment, standardized anesthesia, early mobilization, and timely removal of unnecessary tubes. Their implementation differs between cardiac, pulmonary, and esophageal operations because the physiological and reconstructive demands are not identical.
Recovery extends beyond hospital discharge. Cardiac rehabilitation after appropriate cardiac operations addresses exercise capacity, functional recovery, and cardiovascular risk factors within a structured program. Pulmonary rehabilitation and nutritional support have roles in selected thoracic populations. Outcomes include survival, freedom from reintervention, exercise tolerance, independence, and quality of life. A technically successful procedure may not restore previous function immediately, particularly after prolonged critical illness or extensive organ resection. Conversely, improvements in symptoms and daily activity may be substantial even when residual disease or anatomical abnormalities remain.
Evidence, training, quality measurement, and access
Cardiothoracic surgery combines highly standardized procedures with operations that require individualized anatomical judgment. Training therefore includes operative technique, cardiopulmonary physiology, imaging interpretation, intensive care, and the management of complications. Pathways differ among countries: some begin with general surgery before specialist training, while others use integrated programs. Congenital cardiac surgery, transplantation, complex aortic surgery, and advanced thoracic oncology often require additional concentrated experience.
The operating surgeon works within a multidisciplinary system involving anesthesiologists, perfusionists, nurses, intensivists, cardiologists, respiratory physicians, oncologists, radiologists, pathologists, rehabilitation professionals, and other specialists. Structured communication is particularly important when responsibility transfers between the operating room, intensive care unit, ward, and outpatient services. Simulation allows practice of anastomosis, endoscopic instrument handling, emergency conversion, and crisis management without exposing patients to the earliest stages of technical learning.
Comparative evaluation uses randomized controlled trials, observational registries, and long-term follow-up. Surgical trials face difficulties involving operator experience, procedural variation, crossover between treatments, and rapid technological change. A new device may be compared with established surgery while both treatments continue to evolve. Short-term outcomes may also differ from late durability: a less invasive procedure can reduce initial recovery time yet require separate assessment of reintervention, structural failure, or long-term survival.
Registries maintained by organizations such as the Society of Thoracic Surgeons support outcome measurement across large numbers of operations. Risk-adjusted comparisons account for differences in patient characteristics, but their validity depends on data quality, model design, and the variables available. Operative mortality is not identical to death occurring only in the operating room; registry definitions commonly include a postoperative period and additional rules concerning hospitalization. Complication rates, readmission, resource use, and patient-reported outcomes provide information that mortality alone cannot capture.
Access is constrained by the need for specialized personnel, operating facilities, blood services, intensive care, and reliable follow-up. A catheter-based or robotic technique does not remove these system requirements and may introduce additional infrastructure and maintenance needs. Congenital surgery is especially sensitive to delays in referral and shortages of pediatric intensive care. Transplantation additionally depends on organ donation systems and equitable allocation. Evaluation of a cardiothoracic program consequently includes its capacity to provide timely diagnosis, appropriate treatment selection, rescue from complications, and continuing care—not merely the number or technical complexity of operations performed.